Skip to main content

Table 2 Clinical and biochemical characteristics of episodes at admission

From: Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study

 

Children (N = 39)

Adults (N = 87)

All (N = 126)

Age categories at admission

1–10 years

17 (43.6%)

0

17 (13.5%)

11–15 years

14 (35.9%)

0

14 (11.1%)

 ≥ 15 years

0 (0.0%)

87 (100.0%)

87 (69.0%)

Number of patients/Range of number of episodes per patient

13/1–11

11/1–30

24/1–30

Main precipitating factors

Infectious episodes

16 (41.0%)

25 (28.7%)

41 (32.5%)

Dietary non-adherence

7 (17.9%)

30 (34.5%)

37 (29.4%)

Neonatal/first diagnosis

2 (5.1%)

0 (0.0%)

2 (1.6%)

Vaccination

0 (0.0%)

2 (2.3%)

2 (1.6%)

Stress

0 (0.0%)

2 (2.3%)

2 (1.6%)

Other (no detail)

2 (5.1%)

17 (19.5%)

19 (15.1%)

Missing

12 (30.7%)

11 (12.6%)

23 (18.3%)

Leucine plasma concentration at admission

 < 381 µmol/L (< 5 mg/100 mL)

6 (15.4%)

2 (2.3%)

8 (6.3%)

381–762 µmol/L (5–10 mg/100 mL)

8 (20.5%)

13 (14.9%)

21 (16.7%)

 > 762 µmol/L (10 mg/100 mL)

22 (56.4%)

70 (80.5%)

92 (73.0%)

Missing

3 (7.7%)

2 (2.3%)

5 (4.0%)

  1. SD standard deviation